Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Hypomagnesemia as a possible explanation behind episodes of severe pain in cancer patients receiving palliative care.

López-Saca JM, López-Picazo JM, Larumbe A, Urdíroz J, Centeno C.

Support Care Cancer. 2013 Feb;21(2):649-52. doi: 10.1007/s00520-012-1669-3. Epub 2012 Dec 5.

PMID:
23207922
2.

An update on the importance of monitoring serum magnesium in advanced disease patients.

Centeno C, López Saca JM.

Curr Opin Support Palliat Care. 2013 Dec;7(4):396-405. doi: 10.1097/SPC.0b013e32836575e3. Review.

PMID:
24126921
3.

Cisplatin and hypomagnesemia.

Lajer H, Daugaard G.

Cancer Treat Rev. 1999 Feb;25(1):47-58. Review.

PMID:
10212589
4.

Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.

Schilsky RL, Anderson T.

Ann Intern Med. 1979 Jun;90(6):929-31.

PMID:
375794
5.
6.

Magnesium depletion in patients receiving cisplatin-based chemotherapy.

Hodgkinson E, Neville-Webbe HL, Coleman RE.

Clin Oncol (R Coll Radiol). 2006 Nov;18(9):710-8.

PMID:
17100159
7.

Management of hypomagnesemia in cancer patients receiving chemotherapy.

Saif MW.

J Support Oncol. 2008 May-Jun;6(5):243-8. No abstract available.

PMID:
18551863
8.

Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment.

Hunter RJ, Pace MB, Burns KA, Burke CC, Gonzales DA, Webb NF, Levenback CF, Jhingran A, Parker C, Munsell MF, Smith JA.

Support Care Cancer. 2009 Sep;17(9):1195-201. doi: 10.1007/s00520-008-0574-2. Epub 2009 Jan 27.

PMID:
19172305
9.

Effects of drugs on magnesium requirements.

Zumkley H, Losse H, Spieker C, Zidek W.

Magnesium. 1987;6(1):12-7.

PMID:
3821171
10.

Clinical governance benchmarking issues in oncology: aggressiveness of cancer care and consumption of strong opioids. A single-center experience on measurement of quality of care.

Giovanis P, De Leonardis G, Garna A, Lovat V, Caldart F, Quarta A, Moretto L, Tuccia F, Marcante M, Giusto M.

Tumori. 2010 May-Jun;96(3):443-7.

11.

[Visual hallucinations and unusual pain related to hypomagnesemia in an advanced cancer patient].

Bosch-Barrera J, Urdiroz J, Centeno C.

An Sist Sanit Navar. 2010 Sep-Dec;33(3):319-22. Spanish.

12.

Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin.

Lam M, Adelstein DJ.

Am J Kidney Dis. 1986 Sep;8(3):164-9.

PMID:
3752072
13.

Cetuximab therapy and symptomatic hypomagnesemia.

Schrag D, Chung KY, Flombaum C, Saltz L.

J Natl Cancer Inst. 2005 Aug 17;97(16):1221-4. Review.

14.

Gitelman-like syndrome after cisplatin therapy: a case report and literature review.

Panichpisal K, Angulo-Pernett F, Selhi S, Nugent KM.

BMC Nephrol. 2006 May 24;7:10. Review.

15.

Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia.

van de Loosdrecht AA, Gietema JA, van der Graaf WT.

Acta Oncol. 2000;39(2):239-40. No abstract available.

PMID:
10859019
16.

[Hypomagnesemia associated with hypokalemia, hyponatremia and metabolic alkalosis. Possible complication of gentamycin therapy].

Valdivieso A, Mardones JM, Loyola MS, Cubillos AM.

Rev Med Chil. 1992 Aug;120(8):914-9. Spanish.

PMID:
1340968
17.

Magnesium homeostasis and clinical disorders of magnesium deficiency.

Whang R, Hampton EM, Whang DD.

Ann Pharmacother. 1994 Feb;28(2):220-6. Review.

PMID:
8173141
19.

Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate.

Pistevou-Gombaki K, Eleftheriadis N, Sofroniadis I, Makris P, Kouloulias V.

J Exp Clin Cancer Res. 2002 Sep;21(3):429-32.

PMID:
12385590
20.

cis-Diamminedichloroplatinum-induced hypomagnesemia and renal magnesium wasting.

Bell DR, Woods RL, Levi JA.

Eur J Cancer Clin Oncol. 1985 Mar;21(3):287-90.

PMID:
4040020
Items per page

Supplemental Content

Write to the Help Desk